Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
Feb 06, 2020	SC 13G/A	An amendment to the SC 13G filing	View HTML 0000834237-20-006686.pdf
Jan 28, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-20-000006.pdf 0001237899-20-000006.xls
Jan 27, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-20-000005.pdf 0001237899-20-000005.xls
Jan 13, 2020	8-K	Report of unscheduled material events or corporate event	View HTML 0000930413-20-000068.pdf 0000930413-20-000068.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Jan 06, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-20-000002.pdf 0001708138-20-000002.xls
Jan 06, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-20-000006.pdf 0001708138-20-000006.xls
Jan 06, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-20-000002.pdf 0001237899-20-000002.xls
Jan 06, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-20-000001.pdf 0001237899-20-000001.xls
Jan 06, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-20-000004.pdf 0001237899-20-000004.xls
Jan 06, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-20-000003.pdf 0001237899-20-000003.xls

Data provided by Kaleidoscope.

Investors & Media